RLE-33002-04829
5 vaccinations
3 coded responses
49 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 601 / IL
- Registered
- 2020-12-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-22
Dose 1 — Pfizer-BioNTech
-
2020-12-23
Registered in v-safe
- 2020-12-27
- 2020-12-28
- 2020-12-29
- 2021-01-05
-
2021-01-12
Dose 2 — Pfizer-BioNTech
- 2021-01-12
-
2021-01-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tirednessAdult check-in
-
2021-01-14
Survey response — days 1–6 daily, dose 2MedDRA: Oropharyngeal pain — Feeling: Good · Site: Pain · Fatigue or tirednessFree text: Sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-15
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-19
- 2021-01-26
- 2021-02-02
- 2021-02-09
- 2021-02-16
- 2021-02-23
- 2021-04-13
- 2021-07-15
-
2021-09-30
Dose 3 — Pfizer-BioNTech
- 2022-01-12
-
2022-04-29
Dose 4 — Pfizer-BioNTech
- 2022-04-29
- 2022-04-30
- 2022-05-01
- 2022-05-02
- 2022-05-04
- 2022-05-05
- 2022-05-08
- 2022-05-13
-
2022-05-20
Survey response — day 21, dose 4MedDRA: Headache, Lethargy, Nasal congestion, Oropharyngeal pain, Pain, Pyrexia, Rhinorrhoea — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Sore throat, stuffy/running nose, lethargic, body aches, severe headaches, feverMedDRA releases: 2024-11 · check-in free text available
-
2022-05-27
Survey response — day 28, dose 4MedDRA: Ageusia, Anosmia, Fatigue, Oropharyngeal pain, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Runny nose, sore throat, fatigue, loss of taste and loss of smell,MedDRA releases: 2024-11 · check-in free text available
- 2022-06-04
- 2022-06-10
- 2022-07-29
- 2022-10-28
-
2022-10-30
Dose 5 — Pfizer-BioNTech
- 2022-10-30
-
2022-10-31
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-11-01
- 2022-11-02
- 2022-11-03
- 2022-11-04
- 2022-11-05
- 2022-11-06
- 2022-11-13
- 2022-11-20
- 2022-11-27
- 2022-12-04
- 2022-12-11
- 2023-01-31
- 2023-04-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Pfizer-BioNTech | |
| 2 | 2021-01-12 | Pfizer-BioNTech | |
| 3 | 2021-09-30 | Pfizer-BioNTech | No |
| 4 | 2022-04-29 | Pfizer-BioNTech | No |
| 5 | 2022-10-30 | Pfizer-BioNTech | No |
Free text
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): Sore throat
Release 11 — day 21, dose 4
Symptoms: Sore throat, stuffy/running nose, lethargic, body aches, severe headaches, fever
Release 11 — day 28, dose 4
Symptoms: Runny nose, sore throat, fatigue, loss of taste and loss of smell,
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | · | · | ✓ |
| SD | Anosmia | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Lethargy | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release